Your session is about to expire
← Back to Search
Intracameral Antibiotic Safety Study
Phase 3
Waitlist Available
Research Sponsored by Panhandle Eye Group, LLP
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Pivotal Trial
Summary
The goal of this study is to determine the safety (but not efficacy in preventing infection) of sterile-packaged and pre-loaded injectable solutions of both vancomycin and moxifloxacin at certain dosages and concentrations as prepared by a compounding pharmacy when used intracamerally at the time of cataract surgery.
Eligible Conditions
- Endophthalmitis
- Intracameral Antibiotics
- Cataract Surgery
- Vancomycin
- Moxifloxacin
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Postoperative visual acuity measured by best spectacle corrected
Other study objectives
Endothelial cell count measured by specular microscopy
Awards & Highlights
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Trial Design
3Treatment groups
Experimental Treatment
Placebo Group
Group I: B: MoxifloxacinExperimental Treatment1 Intervention
Intracameral moxifloxacin injection given at conclusion of cataract case
Group II: A: VancomycinExperimental Treatment1 Intervention
Intracameral vancomycin injection given at conclusion of cataract case
Group III: C: PlaceboPlacebo Group1 Intervention
Intracameral placebo injection with BSS given at conclusion of cataract case
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vancomycin
2020
Completed Phase 4
~7920
Moxifloxacin
2013
Completed Phase 4
~3290
Find a Location
Who is running the clinical trial?
Panhandle Eye Group, LLPLead Sponsor
2 Previous Clinical Trials
718 Total Patients Enrolled